Cotransplantation of Limbal Epithelial and Stromal Cells for Ocular Surface Reconstruction
© 2022 by the American Academy of Ophthalmology..
Purpose: To propose an improved stem cell-based strategy for limbal stem cell deficiency (LSCD) treatment.
Design: Experimental randomized or parallel-group animal study.
Subjects: Fifty adult male New Zealand white rabbits.
Methods: Human limbal stem/progenitor cells (LSCs) and limbal stromal stem/progenitor cells (LSSCs) were cultured in serum-free conditions and further differentiated into corneal epithelial cells and keratocytes, respectively. All cell types were characterized with lineage-specific markers. Gene expression analysis was performed to identify the potential function of LSSCs in corneal regeneration. Two LSCD models of rabbits for transplantations were used: transplantation performed at the time of limbal and corneal epithelial excision (LSCD model) and transplantation performed after clinical signs were induced in an LSCD model (pLSCD model). The pLSCD model better mimics the pathologic changes and symptoms of human LSCD. Rabbit models received LSC or LSC plus LSSC treatment. Corneal epithelial defects, neovascularization, and opacity were assessed every 3 weeks for 24 weeks. ZsGreen-labeled LSSCs were used for short-term tracking in vivo.
Main Outcome Measures: Rates of corneal epithelial defect area, corneal neovascularization and opacity scores, graft survival rate, and immunofluorescence staining of specific markers.
Results: Both LSC transplantation and LSC plus LSSC cotransplantation effectively repaired the corneal surface in the LSCD model. These 2 strategies showed no significant differences in terms of graft survival rate or epithelial repair. However, corneal opacity was observed in the LSC group (in 3 of 8 rabbits), but not in the LSC plus LSSC group. Notably, when treating LSCD rabbits with distinguishable stromal opacification and neovascularization, cotransplantation of LSCs and LSSCs exhibited significantly better therapeutic effects than transplantation of LSCs alone, with graft survival rates of 87.5% and 37.5%, respectively. The implanted LSSCs could differentiate into keratocytes during the wound-healing process. RNA sequencing analysis showed that the stromal cells produced not only a collagen-rich extracellular matrix to facilitate reconstruction of the lamellar structure, but also niche factors that accelerated epithelial cell growth and inhibited angiogenesis and inflammation.
Conclusions: These findings highlight the support of stromal cells in niche homeostasis and tissue regeneration, providing LSC plus LSSC cotransplantation as a new treatment strategy for corneal blindness.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:2 |
|---|---|
| Enthalten in: |
Ophthalmology science - 2(2022), 2 vom: 30. Juni, Seite 100148 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Zhu, Liqiong [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Revised 19.10.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.xops.2022.100148 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347646468 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347646468 | ||
| 003 | DE-627 | ||
| 005 | 20231226034325.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.xops.2022.100148 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1158.xml |
| 035 | |a (DE-627)NLM347646468 | ||
| 035 | |a (NLM)36249679 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Zhu, Liqiong |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cotransplantation of Limbal Epithelial and Stromal Cells for Ocular Surface Reconstruction |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 19.10.2022 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2022 by the American Academy of Ophthalmology. | ||
| 520 | |a Purpose: To propose an improved stem cell-based strategy for limbal stem cell deficiency (LSCD) treatment | ||
| 520 | |a Design: Experimental randomized or parallel-group animal study | ||
| 520 | |a Subjects: Fifty adult male New Zealand white rabbits | ||
| 520 | |a Methods: Human limbal stem/progenitor cells (LSCs) and limbal stromal stem/progenitor cells (LSSCs) were cultured in serum-free conditions and further differentiated into corneal epithelial cells and keratocytes, respectively. All cell types were characterized with lineage-specific markers. Gene expression analysis was performed to identify the potential function of LSSCs in corneal regeneration. Two LSCD models of rabbits for transplantations were used: transplantation performed at the time of limbal and corneal epithelial excision (LSCD model) and transplantation performed after clinical signs were induced in an LSCD model (pLSCD model). The pLSCD model better mimics the pathologic changes and symptoms of human LSCD. Rabbit models received LSC or LSC plus LSSC treatment. Corneal epithelial defects, neovascularization, and opacity were assessed every 3 weeks for 24 weeks. ZsGreen-labeled LSSCs were used for short-term tracking in vivo | ||
| 520 | |a Main Outcome Measures: Rates of corneal epithelial defect area, corneal neovascularization and opacity scores, graft survival rate, and immunofluorescence staining of specific markers | ||
| 520 | |a Results: Both LSC transplantation and LSC plus LSSC cotransplantation effectively repaired the corneal surface in the LSCD model. These 2 strategies showed no significant differences in terms of graft survival rate or epithelial repair. However, corneal opacity was observed in the LSC group (in 3 of 8 rabbits), but not in the LSC plus LSSC group. Notably, when treating LSCD rabbits with distinguishable stromal opacification and neovascularization, cotransplantation of LSCs and LSSCs exhibited significantly better therapeutic effects than transplantation of LSCs alone, with graft survival rates of 87.5% and 37.5%, respectively. The implanted LSSCs could differentiate into keratocytes during the wound-healing process. RNA sequencing analysis showed that the stromal cells produced not only a collagen-rich extracellular matrix to facilitate reconstruction of the lamellar structure, but also niche factors that accelerated epithelial cell growth and inhibited angiogenesis and inflammation | ||
| 520 | |a Conclusions: These findings highlight the support of stromal cells in niche homeostasis and tissue regeneration, providing LSC plus LSSC cotransplantation as a new treatment strategy for corneal blindness | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a CEC, corneal epithelial cell | |
| 650 | 4 | |a Corneal regeneration | |
| 650 | 4 | |a Corneal stromal cells | |
| 650 | 4 | |a HAM, human amniotic membrane | |
| 650 | 4 | |a HGF, hepatocyte growth factor | |
| 650 | 4 | |a LSC, limbal stem/progenitor cell | |
| 650 | 4 | |a LSCD, limbal stem cell deficiency | |
| 650 | 4 | |a LSSC, limbal stromal stem/progenitor cell | |
| 650 | 4 | |a Limbal epithelial cells | |
| 650 | 4 | |a Limbal stem cell deficiency | |
| 650 | 4 | |a MSC, mesenchymal stem cell | |
| 650 | 4 | |a PCA, principal component analysis | |
| 650 | 4 | |a SD-OCT, spectral domain OCT | |
| 650 | 4 | |a Stem cell-based therapy | |
| 650 | 4 | |a pLSCD, post–limbal stem cell deficiency | |
| 650 | 4 | |a α-SMA, Alpha smooth muscle actin | |
| 700 | 1 | |a Zhang, Wang |e verfasserin |4 aut | |
| 700 | 1 | |a Zhu, Jin |e verfasserin |4 aut | |
| 700 | 1 | |a Chen, Chaoqun |e verfasserin |4 aut | |
| 700 | 1 | |a Mo, Kunlun |e verfasserin |4 aut | |
| 700 | 1 | |a Guo, Huizhen |e verfasserin |4 aut | |
| 700 | 1 | |a Wu, Siqi |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Huaxing |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Lingyu |e verfasserin |4 aut | |
| 700 | 1 | |a Li, Mingsen |e verfasserin |4 aut | |
| 700 | 1 | |a Tan, Jieying |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Ying |e verfasserin |4 aut | |
| 700 | 1 | |a Wang, Li |e verfasserin |4 aut | |
| 700 | 1 | |a Ouyang, Hong |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Ophthalmology science |d 2021 |g 2(2022), 2 vom: 30. Juni, Seite 100148 |w (DE-627)NLM329259180 |x 2666-9145 |7 nnns |
| 773 | 1 | 8 | |g volume:2 |g year:2022 |g number:2 |g day:30 |g month:06 |g pages:100148 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.xops.2022.100148 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 2 |j 2022 |e 2 |b 30 |c 06 |h 100148 | ||